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Introduction: Many diagnostic tests are used to evaluate 
dry mouth patients, especially the ones with Sjögren’s 
Syndrome, to whom these tests are part of classification 
criteria for scientific studies. Aim: Thus, the concordance 
between results of sialometry and salivary glands scintigraphy 
was evaluated; if positive, it would enable the choice of one 
or the other for diagnosis. Patients and Method: Seventy-
two dry mouth patients were divided into non-Sjögren’s 
Syndrome group, primary Sjögren’s Syndrome group and 
secondary Sjögren’s Syndrome group. The concordance 
among sialometry and scintigraphy results was evaluated by 
Kappa test. Results: It was observed that their concordance 
was equal or near to zero. Conclusion: It is not possible 
to make a choice between these tests and both should be 
performed.
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INTRODUCTION
The assessment of dry mouth complaining patients 
involves a number of questions, both to confirm the com-
plaint as well as to try and define one etiology1,2.
The oral cavity exam may bring important infor-
mation about the oral mucosa situation and the possible 
complications of salivary secretion reduction3,4.
Besides the clinical evaluation, a number of tests 
should be performed in order to determine salivary flow 
alterations1,5. Sjögren’s syndrome is among the various 
causes of dry mouth1,2, and once there is no test to ascer-
tain its diagnosis, there are classification criteria used to 
include patients in the scientific studies6,7.
The criteria used to classify both primary and sec-
ondary Sjögren’s syndrome, has been broadly discussed 
in the international literature.
Such discussion involves not only the set of crite-
ria to be used, in other words, those published by many 
groups, but also the ones from Copenhagen, San Diego, 
the Greek, the Japanese and the ones from the European 
Community Study Group/American-European Consensus, 
but also the tests that should be carried out6-9. At any rate, 
most sets of criteria provide us with options as to the tests 
to be carried out in order to fulfill a certain item of a set 
of criteria.
The European Community Study Group tried to 
validate a number of tests that had their specificity and 
sensitivity tested in this way10,11.
Thus, the ones with the best performance were 
included as part of this set of criteria.
In order to evaluate the involvement of the greater 
salivary glands, they chose salivary gland scintigraphy; 
parotid gland sialography and the non-stimulated salivary 
flow sialometry9-14.
Among them, both the sialometry15-17 and the 
scintigraphy18,19 assess the gland function, not only its 
image.
When altered, any of these tests fulfill the criterion13,14. 
Sialometry is a simple, low cost test, and of easy execution 
as long as the technique is standardized16.
Scintigraphy bears advantages that include the 
saliva quantitative analysis throughout the evaluation of 
radiopharmaceutical build up and salivary escape, which 
may correctly reflect the functional alterations and bring 
information about obstructive clogging of the salivary 
gland.
It may also detect early stages of salivary gland 
involvement18-20. Because sialometry and scintigraphy are 
easily executed tests and provide information about the 
glandular function, often times they are preferred over 
parotid sialography, which is also a more invasive type 
of test.
For these reasons and also because of the great 
current cost concern, let alone the major technological 
innovations, we tried to assess if there would be an cor-
respondence between the salivary gland sialometry and 
the scintigraphy so that, if present, we could chose one 
of the two tests.
MATERIALS AND METHODS
All dry mouth patients who came to the Otolaryn-
gology Department of the Santa Casa de São Paulo, were 
then referred to the stomatology outpatient ward of the 
institution.
From January 1997 until December 2003, 72 patients 
with this complaint were clinically assessed and under-
went diagnostic evaluation and classification, based on the 
criteria established at the American-European Consensus14 
(Chart 1).
 Based on such criteria, these patients were divided 
in 2 groups: one group that did not have Sjögren syndrome 
(NSS) and a group with Sjögren syndrome (SS).
The Sjögren syndrome group was further divided 
in 2 subgroups: with primary Sjögren syndrome (SSp) and 
secondary Sjögren syndrome (SSsec).
In order to classify the patients with primary Sjögren 
syndrome it was necessary to have 4 of the 6 items, items IV 
(histopathology) or VI (autoantibodies) were mandatory.
As far as the secondary Sjögren syndrome patients 
classification is concerned, this was done with the presence 
of either item I or II, plus any other among items III, IV 
and V (Chart 1). Exclusion criteria for Sjögren syndrome 
classification were previous head and neck radiotherapy; 
pre-existent lymphoma; sarcoidosis; graft versus host dis-
ease; anti-cholinergic drug use.
 There was also one Wegener granulomatosis pa-
tient that was excluded.
Criterion V, assessment of major salivary gland 
involvement encompasses, as previously mentioned, an 
altered salivary glands sialometry or scintigraphy, or pa-
rotid sialography.
Non stimulated sialometry was carried out through 
the saliva collection technique using two cotton balls which 
had been previously weighed together with the universal 
collecting 80ml jar, in a digital scale.
Patients were advised to swallow all the saliva they 
had in their oral cavity and the cotton balls were then 
placed on the mouth floor, close to the gingival border, 
where they remained for 2 minutes.
After this time span the whole set was again 
weighed.
The weight difference was directly changed from 
g/min into ml/minute and was considered as altered with 
values below 0.1 ml/minute.
The salivary gland scintigraphy was carried out 
assessing sodium pertechnetate technetium uptake in the 
15 mCi dose and its subsequent clearance after salivary 
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I. Ocular symptoms, positive answer for at least one of the fol-
lowing questions:
 1. Have you had dry eyes daily for more than 3   
 months?
 2. Do you have a recurrent feeling of sand in your   
 eyes?
 3. Do use artificial tears more than three times daily?
II. Oral symptoms, positive answer to at least one of the follow-
ing questions:
 1. Have you had daily symptoms of dry mouth for   
 more than three months?
 2. Have you had recurrent or persistent salivary gland  
 enlargement as an adult?
 3. Do you frequently drink something in order to help  
 you swallow dry food?
III. Ocular involvement signs: positive result for one of the follow-
ing two tests:
 • Schirmer test I (< or = 5 mm in 5 min);
 • Bengal Pink or other dye test (> or = to 4).
IV. histopathology: one or more foci (cluster of 50 or more in-
flammatory cells) by 4mm2 of glandular tissue in minor salivary 
gland biopsy.
V. Salivary gland involvement, positive result for one of the fol-
lowing diagnostic tests:
 • Non-stimulated total salivary flow sialometry < or =  
 to 1.5 ml in 15 minutes;
 • Parotid Sialography showing diffuse sialectasis,   
 without evidence of obstruction of the larger ducts;
 • Salivary scintigraphy with uptake delay, reduction in  
 the concentration and/or delay in tracer secretion.
 VI. Auto-antibodies, presence of one or both: Anti-Ro (SS-A) or 
anti-La (SS-B) antibodies
Chart 1. Sjögren syndrome classification criteria
Fonte: VITALI et al (2002).
stimulation with 8 ml of lemon juice on the tongue dorsum, 
20 minutes after the radiopharmaceutical injection.
Scintigraphies with delayed uptake; reduced 
concentration and/or delay in the tracer secretion were 
considered altered. The statistical methodology used was 
the Kappa measure, which is an correspondence measure 
where the 0 value indicates no correspondence and the 1 
value indicates total correspondence.
Kappa was then calculated for the NSS, SSp, and 
SSsec groups and for all the patients.
In order to check whether the correspondence 
was reasonable, a statistical test was carried out to assess 
Kappa significance.
The significance index used was 5%. The Institution 
Ethics Committee approved such research. 
RESULTS
The Kappa values found were different from zero 
for all cases and for the NSS group, however for the SSp 
and SSsec groups, such values were equal to zero (Table 
1). In groups where the correspondence index was dif-
ferent from zero, the values were very low. 
Table 1. Kappa results calculated for the different groups
Kappa Standard error p
All cases 0,22 0,09 0,018
NSS Group 0,36 0,11 0,003
SSp Group -0,11 0,10 0,506
SSsec Group -0,23 0,21 0,236
NSS = non-Sjögren syndrome; SSp = primary Sjögren syn-
drome; SSsec = secondary Sjögren syndrome
DISCUSSION
According to the current attempt to reduce costs, if 
it were possible to choose between one of the tests, the 
choice would be the sialometry, because it is a low cost 
test that does not expose the patient to radiation.
The very fact of the Kappa index that assesses the 
correspondence of the test results be equal to zero or 
very low, indicates that we may not choose one of the 
tests only.
This low or absent correspondence may be due to 
the fact that sialometry assesses glandular function only, 
while scintigraphy also assesses radioisotope uptake by the 
gland, that may be influenced by circulatory alterations.
 At any rate, both tests may be subject to vari-
ations related to fluctuations in the quantity of saliva 
produced.
This fact alone confirms the need to use diagnostic 
criteria that involve more then one test to assess the in-
volvement of the greater salivary glands. 
CONCLUSION
Both sialometry and scintigraphy should be carried 
out in order to assess the involvement of salivary glands 
in patients complaining of dry mouth, specially in Sjögren 
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syndrome patients, since one can not replace the other be-
cause of a lack of correspondence among their results. 
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